Acasti Pharma Inc (ACST.V)

Healthcare | Biotechnology
Income Statement (Quarterly) 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue 0 0 0 0
Cost of Revenue 0 0 2,000 0
Gross Profit 0 0 -2,000 0
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 1,961,000 2,133,000 1,547,000 1,509,000
Operating Expenses 2,529,000 3,090,000 3,181,000 3,704,000
Operating Income -2,529,000 -3,090,000 -3,183,000 -3,704,000
Interest Expense 0 0 0 0
Income Before Tax -938,000 -3,362,000 -382,000 -4,760,000
Income Tax Expense 0 0 -1,018,000 -605,000
Net Income -938,000 -3,362,000 636,000 -4,155,000
Per Share
EPS -0.06 -0.21 0.05 -0.36
EPS Diluted 0.00 0.00 0.00 0.00
Income Statement (Annual) 2025-03-31 2024-03-31 2022-12-31
Revenue 0 0 14,249,000
Cost of Revenue 0 11,000 67,215,000
Gross Profit 0 -11,000 -52,966,000
Operating Expenses
R&D Expenses 0 0 0
SG&A Expenses 7,161,000 6,673,000 20,189,000
Operating Expenses 16,679,000 11,301,000 12,665,000
Operating Income -16,679,000 -11,312,000 -73,155,000
Interest Expense 0 0 0
Income Before Tax -12,767,000 -14,630,000 -64,685,000
Income Tax Expense -3,199,000 -1,777,000 230,000
Net Income -9,568,000 -12,853,000 -64,915,000
Per Share
EPS -0.79 -1.73 -0.99
EPS Diluted 0.00 0.00 0.00
Balance Sheet (Quarterly) 2025-03-31 2024-03-31 2022-12-31
Assets
Cash and Cash Equivalents 22,133,000 23,005,000 112,488,000
Short Term Investments 0 0 0
Net Receivables 126,000 722,000 6,533,000
Inventory 0 0 1
Total Current Assets 22,712,000 24,010,000 147,196,000
Property Plant Equipment 15,000 24,000 21,976,000
Goodwill and Intangibles 49,266,000 49,266,000 0
Total Assets 71,993,000 73,300,000 170,454,000
Liabilities
Account Payables 601,000 1,007,000 5,488,000
Short Term Debt 0 0 0
Total Current Liabilities 1,930,000 1,684,000 35,632,000
Long Term Debt 0 0 911,000
Total Liabilities 5,383,000 11,557,000 67,937,000
Shareholders Equity
Retained Earnings -220,687,000 -211,119,000 -287,681,000
Total Shareholders Equity 66,610,000 61,743,000 102,517,000
Balance Sheet (Annual) 2025-03-31 2024-03-31 2022-12-31
Assets
Cash and Cash Equivalents 22,133,000 23,005,000 112,488,000
Short Term Investments 0 0 0
Net Receivables 126,000 722,000 6,533,000
Inventory 0 0 1
Total Current Assets 22,712,000 24,010,000 147,196,000
Property Plant Equipment 15,000 24,000 21,976,000
Goodwill and Intangibles 49,266,000 49,266,000 0
Total Assets 71,993,000 73,300,000 170,454,000
Liabilities
Account Payables 601,000 1,007,000 5,488,000
Short Term Debt 0 0 0
Total Current Liabilities 1,930,000 1,684,000 35,632,000
Long Term Debt 0 0 911,000
Total Liabilities 5,383,000 11,557,000 67,937,000
Shareholders Equity
Retained Earnings -220,687,000 -211,119,000 -287,681,000
Total Shareholders Equity 66,610,000 61,743,000 102,517,000
Cash Flow Statement (Quarterly) 2025-03-31 2024-03-31 2022-12-31
Operating Activities
Net Income -9,568,000 -12,853,000 -64,915,000
Depreciation & Amortization 7,000 11,000 3,602,000
Stock Based Compensation 730,000 913,000 5,043,000
Change in Working Capital 342,000 -1,280,000 -341,000
Operating Cash Flow -14,904,000 -12,333,000 -19,997,000
Investing Activities
Capital Expenditure 0 -22,000 -5,017,000
Investments 0 -22,000 -5,017,000
Investing Cash Flow 0 104,000 -5,017,000
Financing Activities
Debt Repayment 0 0 -2,850,000
Common Stock Issued/Repurchased 14,999,000 7,338,000 0
Dividends Paid 0 0 0
Financing Cash Flow 14,032,000 7,359,000 72,271,000
Summary
Free Cash Flow -14,904,000 -12,355,000 -25,014,000
Net Change in Cash -872,000 -4,870,000 46,532,000
Cash Flow Statement (Annual) 2025-03-31 2024-03-31 2022-12-31
Operating Activities
Net Income -9,568,000 -12,853,000 -64,915,000
Depreciation & Amortization 7,000 11,000 3,602,000
Stock Based Compensation 730,000 913,000 5,043,000
Change in Working Capital 342,000 -1,280,000 -341,000
Operating Cash Flow -14,904,000 -12,333,000 -19,997,000
Investing Activities
Capital Expenditure 0 -22,000 -5,017,000
Investments 0 -22,000 -5,017,000
Investing Cash Flow 0 104,000 -5,017,000
Financing Activities
Debt Repayment 0 0 -2,850,000
Common Stock Issued/Repurchased 14,999,000 7,338,000 0
Dividends Paid 0 0 0
Financing Cash Flow 14,032,000 7,359,000 72,271,000
Summary
Free Cash Flow -14,904,000 -12,355,000 -25,014,000
Net Change in Cash -872,000 -4,870,000 46,532,000